Physicians are vital to our organization and our mission of helping people do more, feel better, live longer. We rely on the expertise and insight of doctors and other healthcare professionals to understand patient needs, and help us to develop new treatments that will best address these needs.
We are introducing new ways for physicians to join GSK in R&D or in medical affairs, aimed at attracting the right people, the best people, who want to help us change the way we interact with healthcare professionals.
For those physicians and medical researchers who share our goal of helping people around the world, GSK can offer a range or opportunities. Being part of our global business can mean physicians have the chance to reach even more people.
Areas of opportunity
In R&D, our clinician researchers help to bridge the gap between bench-side science and medicine. They bring knowledge of patients and the patient needs into the discovery and development of new treatments to address major healthcare challenges like antibiotic resistance, respiratory conditions, and diseases linked to immuno-inflammation.
Our medical affairs physicians are the experts on our medicines and are a valuable part of our business. In the countries where our medicines and vaccines are marketed, these professionals help to ensure that prescribers can understand the appropriate use of our medicines.
From leading experts to newly qualified doctors, we offer physicians the chance to have a number of different roles, even global assignments, across the medical spectrum and at every stage of their careers. Our physicians come from all over – including globally-renowned experts.
Some of our physicians balance their work at GSK with continuing to see patients, and many know that they will return to full time practice one day. Many have also taken advantage of our global development and leadership programmes, including our future leadership scheme and Medical Fellowships.
Our physicians are at the forefront of the industry-leading changes we are introducing to the way we operate. These changes will update our relationship with the scientific and medical community and ensure we are responding to the needs of patients and meeting the wider expectations of society.